Target intelligence / Profile preview

Intraflagellar transport protein 27 homolog (IFT27)

Target
IFT27
Molecular classification
Small GTPase, Rab-like GTP-binding protein, Intraflagellar transport complex B (IFT-B) core subunit
01

Overview

IFT27 is a small Rab-like GTP-binding protein that forms a core part of the IFT-B complex required for the assembly and maintenance of cilia and flagella in eukaryotic cells[1][2][3][4]. It functions in both anterograde and retrograde intraflagellar transport by mediating the import and assembly of complex A and B proteins and is essential for cargo loading of retrograde transport machinery[1][2]. IFT27 acts together with IFT25, interacts directly with nucleotide-free ARL6 to help assemble the BBSome coat, and is required for proper ciliary signaling, including the removal of Patched-1 and Smoothened receptors during Hedgehog signaling[3]. Knockdown or mutation of IFT27 disrupts flagellar assembly, ciliary signaling, and can result in cell cycle and cytokinesis defects[2]. Although highly conserved, IFT27 is not present in certain model organisms whose ciliated cells are terminally differentiated[2].

Other names
RABL4Rab-like protein 4Putative GTP-binding protein RAY-likeBBS19CFAP156FAP156RAYL
02

Biological functions

Protein trafficking within cilia/flagellaRegulation of cargo loading and bidirectional movement during IFT (anterograde and retrograde)Cellular signaling regulation in cilia (e.g., Hedgehog pathway receptor trafficking)Cell cycle control and cytokinesis
03

Disease associations

Ciliopathies (genetic disorders of cilia)Bardet-Biedl syndrome (through interaction with ARL6 and BBSome; possible indirect link)Cell cycle defects (evidence from model organisms; lethality with complete knockdown)
04

Safety considerations

Not a therapeutic target; no known safety concerns related to pharmacological modulation. Mutations result in cell division and ciliary defects, implying loss-of-function risks for cell biology studies[2].

Beyond the preview

Go deeper on Intraflagellar transport protein 27 homolog (IFT27).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intraflagellar transport protein 27 homolog (IFT27).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call